These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2329721)

  • 21. Reconstitution of hepatitis B virus (HBV)-specific T cell responses with treatment of human immunodeficiency virus/HBV coinfection.
    Lascar RM; Gilson RJ; Lopes AR; Bertoletti A; Maini MK
    J Infect Dis; 2003 Dec; 188(12):1815-9. PubMed ID: 14673759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon.
    Kuaban C; Bercion R; Koulla-Shiro S
    East Afr Med J; 1997 Aug; 74(8):474-7. PubMed ID: 9487410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and laboratory observation on the effect of glycyrrhizin in acute and chronic viral hepatitis.
    Su XS; Chen HM; Wang LH; Jiang CF; Liu JH; Zhao MQ; Ma XH; Zhao YC; Han DW
    J Tradit Chin Med; 1984 Jun; 4(2):127-32. PubMed ID: 6567725
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of HIV infection on leprosy: a three-year survey in Bamako, Mali.
    Lienhardt C; Kamate B; Jamet P; Tounkara A; Faye OC; Sow SO; Bobin P
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):383-91. PubMed ID: 9030103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinico-epidemiological patterns of HIV infection in STD patients in Ibadan.
    Ekweozor CC; Olaleye OD; Tomori O; Saliu I; Essien EM; Bakare RA; Oni AA; Oyewo OO; Okesola AO; Onyemenem TN
    Afr J Med Med Sci; 1995 Dec; 24(4):321-7. PubMed ID: 8886145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-HIV activity of the combination of didanosine and hydroxyurea in HIV-1-infected individuals.
    Biron F; Lucht F; Peyramond D; Fresard A; Vallet T; Nugier F; Grange J; Malley S; Hamedi-Sangsari F; Vila J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):36-40. PubMed ID: 7648282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human immunodeficiency virus type 1 and type 2 seroprevalence in cornea donors.
    Geier SA; Klauss V; Gürtler L
    Ger J Ophthalmol; 1994 May; 3(3):182-5. PubMed ID: 7864930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C at the israeli national hemophilia center.
    Maor Y; Bashari D; Kenet G; Lalezari S; Lubetsky A; Luboshitz J; Schapiro JM; Avidan B; Bar-Meir S; Martinowitz U
    Haemophilia; 2006 Jan; 12(1):68-74. PubMed ID: 16409178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of human immunodeficiency virus (HIV) antibodies in tuberculosis patients in Lagos, Nigeria.
    Idigbe EO; Nasidi A; Anyiwo CE; Onubogu C; Alabi S; Okoye R; Ugwu O; John EK
    J Trop Med Hyg; 1994 Apr; 97(2):91-7. PubMed ID: 8170009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-HIV antibodies in patients receiving intravenous immunoglobulin.
    Bloom RD; Triglia D; Asser S
    Ann Allergy; 1988 Jul; 61(1):30-4. PubMed ID: 3133965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination therapy of glycyrrhizin withdrawal and human fibroblast interferon for chronic hepatitis B.
    Hayashi J; Kashiwagi S; Noguchi A; Ikematsu H; Tsuda H; Tsuji Y; Motomura M
    Clin Ther; 1989; 11(1):161-9. PubMed ID: 2497983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AIDS studies in Japan.
    Harada S; Yamamoto N
    Jpn J Cancer Res; 1987 May; 78(5):415-27. PubMed ID: 3112053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human immunodeficiency virus infection in hemodialysis patients. Baltimore-Boston Collaborative Study Group.
    Arch Intern Med; 1988 Mar; 148(3):617-9. PubMed ID: 3341863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pediatric acquired immunodeficiency syndrome with negative human immunodeficiency virus antibody response by enzyme-linked immunosorbent assay and Western blot.
    Goetz DW; Hall SE; Harbison RW; Reid MJ
    Pediatrics; 1988 Mar; 81(3):356-9. PubMed ID: 2449652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV seropositivity in Nigerians with lymphoproliferative malignancies.
    Okpala IE; Shokunbi WA; Saliu I; Akinboye DO; Essien EM
    Afr J Med Med Sci; 1993 Dec; 22(4):73-6. PubMed ID: 7839934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [HIV seroprevalence in patients with tuberculosis].
    Nagai H; Kawabe Y; Nagayama N; Tanaka Y; Nishiyama M; Suzuki M; Masuda K; Baba M; Hori A; Tamura A; Akagawa S; Machida K; Kurashima A; Yotsumoto H; Mori M; Kimura S
    Kekkaku; 2001 Nov; 76(11):679-84. PubMed ID: 11766358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Horizontal versus vertical transmission of human immunodeficiency virus type 1 (HIV-1). Experience from southwestern Saudi Arabia.
    al-Nozha MM; al-Frayh AR; al-Nasser M; Ramia S
    Trop Geogr Med; 1995; 47(6):293-5. PubMed ID: 8650743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [HIV and blood donors: past, present and future].
    León de González G; Hernández T; Arias F; Celis S; Acosta V; Semprún O; Lugo de Morón M
    Sangre (Barc); 1994 Feb; 39(1):15-21. PubMed ID: 8197513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of adenine-arabinosine with glycyrrhizin in treating chronic active hepatitis].
    Zhang ZH; Yang ZH
    Zhong Xi Yi Jie He Za Zhi; 1988 Mar; 8(3):150-1, 157, 132-3. PubMed ID: 3416396
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of Stronger Neo-Minophagen C compared between two doses administered three times a week on patients with chronic viral hepatitis.
    Miyake K; Tango T; Ota Y; Mitamura K; Yoshiba M; Kako M; Hayashi S; Ikeda Y; Hayashida N; Iwabuchi S; Sato Y; Tomi T; Funaki N; Hashimoto N; Umeda T; Miyazaki J; Tanaka K; Endo Y; Suzuki H
    J Gastroenterol Hepatol; 2002 Nov; 17(11):1198-204. PubMed ID: 12453280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.